At NYU

  1. Our first paper on cancer immunology recently came out at Cell! Congratulations to Xufeng and Qiao! This was great collaboration with Dr. Iannis Aifantis lab! Many thanks to the generous support from Mark Foundation!
  2. Our first research paper is online at Immunity! Congratulations Qiao and Jia! We also thank our colleagues at NYULH as well as our collaborators for their strong support along the road that make it happen!
  3. Welcome Jasper Du to join Wang Lab! March, 2021
  4. A burn-out CD8+ T-cell subset expands in the tumour microenvironment limiting cancer immunotherapy, Cancer Discovery, March, 2021
  5. Our review paper on Siglec-15 as an emerging target for next-generation cancer immunotherapy is published at Clinical cancer research, Feb., 2021.
  6. Our commentary paper on Immune asynchrony in COVID-19 immunopathogenesis and potential immunotherapies is published at JEM, Oct., 2020!
  7. Jun received a special award from NYU Colton Center for Autoimmunity Pilot Project to study immunotherapy for autoimmune diseases! September, 2020  
  8. Jun received a special award from NYU OSR (Office of Science & Research) to study COVID-19 immunopathogenesis! August, 2020   
  9. Jun received a special award from NYU Melanoma SPORE Career Enhancement Program regarding FGL1/LAG-3 in melanoma immunity! July, 2020              
  10. Jun received the prestigious the Team Science Award from Melanoma Research Alliance with Dr. Tomas Kirchhoff etc as an Young investigator!  July, 2020 
  11. Jun receives a special award from NYU Perlmutter Cancer Center Development Projects Program regarding Siglec-15 in cancer immunotherapy! June, 2020 
  12. IL-18BP is a secreted immune checkpoint and barrier to effective IL-18 Immunotherapy, Nature, July, 2020.
  13. Our S100A4 paper on HCC carcinogenesis was published in Oncoimmunology, Jan., 2020
  14. Welcome Jia Liu and Ariana Bitton to join Wang Lab! Oct.,2019
  15. Jun Wang Ph.D. joins Perlmutter Cancer Center! Oct.2019
  16. Our collaborator, Dario Vignali published a nice review paper in Nature Immunology regarding breakthroughs in LAG3 biology and the clinical development! Oct.,2019
  17. Welcome Qiao Lu to join Wang Lab as our first Postdoc Fellow! Sep., 2019
  18. Wang Lab at NYU officially started! Aug.,2019

Before NYU

  1. Jun's commentary paper on anti-4-1BB clinical development is published in Clinical Cancer Research, July, 2019
  2. Our collaborators at Yale by Dr. David Rimm’s group published an abstract in AACR showing Siglec-15 expression in non-small cell lung cancers and its association with PD-L1, B7-H4 and tumor infiltrating lymphocytes. April, 2019
  3. NextCure initiates Clinical Development for NC318, a Siglec-15 Targeting Antibody, for Solid Tumors. Oct.,2018
  4. Our Siglec-15 paper digested by ACIR. March, 2019
  5. NextCure and Yale Publish Nature Medicine Paper detailing novel immunomedicine target Siglec15. March 2019
  6. New Ligand for LAG3, commented by Ioana Visan, Nature Immunology, Jan., 2019
  7. Yale Cancer Center Scientists advice caution in immunotherapy research, Dec., 2019
  8. Fibrinogen-like Protein 1 is a major Immune Inhibitory Ligand of LAG-3, Cell, Dec.,2019